Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP324262.RAS6jySCg0Rz1yopw79d4SdroB2K4eWX862sdvAI-wKbU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP324262.RAS6jySCg0Rz1yopw79d4SdroB2K4eWX862sdvAI-wKbU130_assertion type Assertion NP324262.RAS6jySCg0Rz1yopw79d4SdroB2K4eWX862sdvAI-wKbU130_head.
- NP324262.RAS6jySCg0Rz1yopw79d4SdroB2K4eWX862sdvAI-wKbU130_assertion description "[Until recently, pharmacologic intervention in the RAS has focused on the ACE step, with documented success being reported in the prevention of diabetic nephropathy and ESRD using ACE inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP324262.RAS6jySCg0Rz1yopw79d4SdroB2K4eWX862sdvAI-wKbU130_provenance.
- NP324262.RAS6jySCg0Rz1yopw79d4SdroB2K4eWX862sdvAI-wKbU130_assertion evidence source_evidence_literature NP324262.RAS6jySCg0Rz1yopw79d4SdroB2K4eWX862sdvAI-wKbU130_provenance.
- NP324262.RAS6jySCg0Rz1yopw79d4SdroB2K4eWX862sdvAI-wKbU130_assertion SIO_000772 11459212 NP324262.RAS6jySCg0Rz1yopw79d4SdroB2K4eWX862sdvAI-wKbU130_provenance.
- NP324262.RAS6jySCg0Rz1yopw79d4SdroB2K4eWX862sdvAI-wKbU130_assertion wasDerivedFrom befree-2016 NP324262.RAS6jySCg0Rz1yopw79d4SdroB2K4eWX862sdvAI-wKbU130_provenance.
- NP324262.RAS6jySCg0Rz1yopw79d4SdroB2K4eWX862sdvAI-wKbU130_assertion wasGeneratedBy ECO_0000203 NP324262.RAS6jySCg0Rz1yopw79d4SdroB2K4eWX862sdvAI-wKbU130_provenance.